Connection

Elizabeth Garrett-Mayer to Drugs, Investigational

Back to Details
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Drugs, Investigational.
Elizabeth Garrett-Mayer
Connection Strength
0.083
Drugs, Investigational
  1. Approaches to phase 1 clinical trial design focused on safety, efficiency, and selected patient populations: a report from the clinical trial design task force of the national cancer institute investigational drug steering committee. Clin Cancer Res. 2010 Mar 15; 16(6):1726-36.
    View in: PubMed
    Score: 0.083
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.